title: Transcatheter aortic valve implantation: the transfemoral access route is the default access.
abstract: Transcatheter aortic valve implantation (TAVI) is a widely accepted alternative to surgical aortic valve replacement (SAVR) among non-operable patients or selected high-risk patients with degenerative, severe aortic stenosis. TAVI is considered less invasive when compared with SAVR; however, there remain significant differences between different TAVI access routes. The transfemoral approach is considered the least invasive access route, and can be performed as a fully percutaneous procedure in a spontaneously breathing patient under local anaesthesia and mild sedation only. Moreover, transfemoral TAVI patients are typically transferred to coronary care rather than to an intensive care unit after the procedure, and benefit from early ambulation and a reduction in overall length of hospital stay. Considering these patient-specific and health-economic advantages, several TAVI centres follow the least invasive strategy for their patients and have implemented the transfemoral access route as the default access in their institutions. This article provides an overview on the prerequisites for a successful transfemoral TAVI procedure, describes the procedural advantages compared to alternative access routes, and highlights differences in clinical outcomes.
authors.affiliation: Swiss Cardiovascular Centre, Department of Cardiology, University Hospital, Bern, Switzerland.
authors.forename: Stefan
authors.initials: S
authors.lastname: Stortecky
authors.forename: Crochan J
authors.initials: CJ
authors.lastname: O'Sullivan
authors.forename: Lutz
authors.initials: L
authors.lastname: Buellesfeld
authors.forename: Stephan
authors.initials: S
authors.lastname: Windecker
authors.forename: Peter
authors.initials: P
authors.lastname: Wenaweser
mesh_terms: D000792:Angiography; D001021:Aortic Valve; D001024:Aortic Valve Stenosis / Q000628:therapy*; D006328:Cardiac Catheterization / Q000191:economics / Q000295:instrumentation / Q000379:methods*; D006348:Cardiac Surgical Procedures / Q000191:economics / Q000295:instrumentation / Q000379:methods; D003362:Cost-Benefit Analysis; D004864:Equipment and Supplies; D005263:Femoral Artery; D019918:Heart Valve Prosthesis Implantation / Q000191:economics / Q000295:instrumentation / Q000379:methods*; D006801:Humans; D016896:Treatment Outcome